Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-024716 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 10, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
242,031
Total Value
$5,173,854.34
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Dev. & Operating Officer | Common Stock | โ | Apr 8, 2026 | Exercise/Conversion | 49,474 | $23.98 | $1,186,386.52 | 161,492 | Direct | โ | View Details | |
Chief Dev. & Operating Officer | Common Stock | โ | Apr 8, 2026 | Exercise/Conversion | 9,624 | $20.02 | $192,672.48 | 171,116 | Direct | โ | View Details | |
Chief Dev. & Operating Officer | Common Stock | โ | Apr 8, 2026 | Exercise/Conversion | 19,336 | $19.64 | $379,759.04 | 190,452 | Direct | โ | View Details | |
Chief Dev. & Operating Officer | Common Stock | โ | Apr 8, 2026 | Sale | 85,163 | $40.10 | $3,415,036.30 | 105,289 | Direct | โ | View Details | |
Chief Dev. & Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 8, 2026 | Exercise/Conversion | 49,474 | $0.00 | $0.00 | 63,027 | Direct | โ | View Details | |
Chief Dev. & Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 8, 2026 | Exercise/Conversion | 9,624 | $0.00 | $0.00 | 10,589 | Direct | โ | View Details | |
Chief Dev. & Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 8, 2026 | Exercise/Conversion | 19,336 | $0.00 | $0.00 | 65,977 | Direct | โ | View Details |